Mode
Text Size
Log in / Sign up

Five-variable admission model predicts 90-day outcomes in 245 aneurysmal subarachnoid hemorrhage patients

Five-variable admission model predicts 90-day outcomes in 245 aneurysmal subarachnoid hemorrhage pat…
Photo by Nick Fewings / Unsplash
Key Takeaway
Consider this five-variable model for early risk stratification in aSAH, noting less stable calibration in older patients.

This observational cohort study included 245 consecutive treatment-eligible patients with aneurysmal subarachnoid hemorrhage managed at a single center. The exposure was an admission-based five-variable model incorporating age, pre-morbid modified Rankin Scale score, World Federation of Neurosurgical Societies grade, modified Fisher grade, and intracerebral hemorrhage on initial computed tomography. The primary outcome was the 90-day modified Rankin Scale score of 0 to 3 points, with secondary outcomes including 90-day modified Rankin Scale scores of 0 to 2.

The model showed good discrimination with an AUC of 0.917 in the development cohort and 0.868 in the validation cohort for the primary outcome. For the secondary outcome, the AUC was 0.920 in the development cohort and 0.840 in the validation cohort. In patients aged 70 years or older, the AUC for the primary outcome was 0.842 and for the secondary outcome was 0.768 in the validation cohort, indicating less stable calibration.

Safety data, adverse events, and discontinuations were not reported. Key limitations include the single-center design and less stable calibration in older patients. Pending multicenter external validation is required before broader adoption. The study may facilitate early risk stratification at admission, but results should be interpreted with caution given the lack of external validation and observational design.

Study Details

Study typeCohort
Sample sizen = 245
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Early prognostic stratification of aneurysmal subarachnoid hemorrhage (aSAH) is clinically important. We developed and temporally validated an admission-based prediction model for 90-day outcomes in a cohort of patients with aSAH. METHODS: Consecutive treatment-eligible patients with aSAH, managed at a single center between January 2021 and December 2025, were retrospectively analyzed. Patients treated from 2021?2023 and 2024?2025 comprised the development and temporal validation cohorts, respectively. Prediction models were developed using admission variables, including age, pre-morbid modified Rankin Scale (mRS) score, World Federation of Neurosurgical Societies grade, modified Fisher grade, and intracerebral hemorrhage on initial computed tomography. The primary outcome was a 90-day mRS score of 0?3 points. A sensitivity model was constructed for 90-day mRS scores of 0?2. RESULTS: A total of 245 patients were included (development cohort: 160; validation cohort: 85); 107 patients were aged ? 70 years. For mRS 0?3, the model demonstrated good discrimination in both the development and validation cohorts (area under the curve [AUC]: 0.917 and 0.868), while mRS 0?2 had corresponding AUCs of 0.920 and 0.840, respectively. Among patients aged ? 70 years, the validation AUCs were 0.842 and 0.768 for mRS scores of 0?3 and 0?2, respectively. Calibration was acceptable overall but less stable in older patients. CONCLUSIONS: In an aSAH cohort with a substantial proportion ofpredominantly older patients, an admission-based five-variable model provided 90-day outcome prediction with good discrimination on temporal validation. This tool may facilitate early risk stratification at admission, pending multicenter external validation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.